Who Supplies Emtricitabine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Emtricitabine exports, with 141+ registered manufacturers shipping to buyers across 117+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 22.8% (export value: $27.2M). Close behind, MACLEODS PHARMACEUTICALS LTD (22.2%, $26.5M). AUROBINDO PHARMA LTD (3.5%, $4.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Emtricitabine? Top Manufacturers & Their Buyers
Flow of Emtricitabine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Emtricitabine Supplier Network — Key Market Intelligence
The Emtricitabine export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 22.8% share, shipping $27.2M worth of product across 265 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $26.5M (22.2%) to the overall market. Combined, the top two suppliers alone account for 44.9% of all Emtricitabine exports, indicating a relatively concentrated supply base.
Across all 141 tracked manufacturers, the total Emtricitabine export value stands at $119.4M from 2.2K shipments. The market average shipment value is $54.4K. The single largest buyer relationship in terms of trade value is VIATRIS HEALTHCARE (PTY) LTD,, receiving $14.0M worth of product.
The combined buyer network spans 22 named purchasing companies, including VIATRIS HEALTHCARE (PTY) LTD,, NATIONAL AIDS COUNCIL (NAC),, EMBASSY OF THE UNITED STATES OF AME, MINISTERIO DE SALUD, SAI PHARMA CO LTD and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Emtricitabine exporter from India, with a market share of 22.8% and a total export value of $27.2M across 265 shipments. Their average shipment value of $102.6K is above the market average of $54.4K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS HEALTHCARE (PTY) LTD, is the dominant customer, accounting for 51.5% of this supplier's tracked business. Top customers include:
• VIATRIS HEALTHCARE (PTY) LTD, — $14.0M across 136 shipments (51.5% of this supplier's total exports)
• NATIONAL AIDS COUNCIL (NAC), — $9.9M across 96 shipments (36.3% of this supplier's total exports)
• EMBASSY OF THE UNITED STATES OF AME — $1.2M across 12 shipments (4.6% of this supplier's total exports)
• MINISTERIO DE SALUD — $1.1M across 10 shipments (3.9% of this supplier's total exports)
• SAI PHARMA CO LTD — $997.3K across 10 shipments (3.7% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $102.6K is 89% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Emtricitabine exporter from India, with a market share of 22.2% and a total export value of $26.5M across 280 shipments. Their average shipment value of $94.5K is above the market average of $54.4K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MACLEODS PHARMACEUTICALS SA — $11.3M across 119 shipments (42.5% of this supplier's total exports)
• ZYDUS FRANCE — $8.1M across 86 shipments (30.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M across 38 shipments (13.6% of this supplier's total exports)
• ICU VITA — $2.0M across 22 shipments (7.7% of this supplier's total exports)
• SYNOPTIS INDUSTRIAL SP .ZO.O — $1.4M across 15 shipments (5.5% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $94.5K is 74% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.
3AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the third-largest Emtricitabine exporter from India, with a market share of 3.5% and a total export value of $4.2M across 118 shipments. Their average shipment value of $35.7K is below the market average of $54.4K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• APL SWIFT SERVICES (MALTA) LTD., — $1.7M across 48 shipments (41.0% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.3M across 36 shipments (30.8% of this supplier's total exports)
• AUROBINDO PHARMA USA — $568.9K across 16 shipments (13.5% of this supplier's total exports)
• QUALLENT PHARMACEUTI — $316.9K across 9 shipments (7.5% of this supplier's total exports)
• AUROBINDO PHARMA USA — $300.9K across 8 shipments (7.2% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (118 shipments) at a per-shipment value of $35.7K, indicating a broad distribution network with many smaller, regular orders.
4LUPIN LIMITED
LUPIN LIMITED is the fourth-largest Emtricitabine exporter from India, with a market share of 3.0% and a total export value of $3.6M across 43 shipments. Their average shipment value of $82.9K is above the market average of $54.4K, suggesting premium or bulk contract pricing.
LUPIN LIMITED serves 5 named buyers in our database. LUPIN HEALTHCARE (UK) LIMITED is the dominant customer, accounting for 61.7% of this supplier's tracked business. Top customers include:
• LUPIN HEALTHCARE (UK) LIMITED — $2.2M across 27 shipments (61.7% of this supplier's total exports)
• LUPIN HEALTHCARE (UK) LIMITED — $675.6K across 8 shipments (19.0% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS EUROPE LTD — $254.8K across 3 shipments (7.2% of this supplier's total exports)
• TRANS-O-FLEX LOGISTI — $237.4K across 3 shipments (6.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS EUROPE LTD — $196.6K across 2 shipments (5.5% of this supplier's total exports)
Key Insight: LUPIN LIMITED's per-shipment value of $82.9K is 52% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.
5HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Emtricitabine exporter from India, with a market share of 2.9% and a total export value of $3.4M across 67 shipments. Their average shipment value of $50.9K is below the market average of $54.4K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $1.8M across 36 shipments (54.0% of this supplier's total exports)
• NA — $967.7K across 19 shipments (28.4% of this supplier's total exports)
• XXN AXXRICXX HEXXTH — $203.7K across 4 shipments (6.0% of this supplier's total exports)
• XXN AXXRICXX HEXXTH — $203.5K across 4 shipments (6.0% of this supplier's total exports)
• M S TO THE ORDER OF — $194.5K across 4 shipments (5.7% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (67 shipments) at a per-shipment value of $50.9K, indicating a broad distribution network with many smaller, regular orders.
6CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Emtricitabine exporter from India, with a market share of 2.2% and a total export value of $2.6M across 40 shipments. Their average shipment value of $65.1K is above the market average of $54.4K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $964.0K across 15 shipments (37.0% of this supplier's total exports)
• CIPLA AUSTRALIA PTY — $597.7K across 9 shipments (22.9% of this supplier's total exports)
• APOTEX AUSTRALIA — $480.0K across 7 shipments (18.4% of this supplier's total exports)
• MEGALABS CHILE S A — $317.7K across 5 shipments (12.2% of this supplier's total exports)
• CIPLA COLOMBIA SAS Y — $246.0K across 4 shipments (9.4% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $65.1K is 20% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Emtricitabine Flows
Once Emtricitabine leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $119.4M. South Africa absorbs the largest share at 26.2% ($31.3M), followed by United States (13.1%) and Zimbabwe (8.7%).
In South Africa — the top destination — named importers include VIATRIS HEALTHCARE (PTY) LTD,, MACLEODS PHARMACEUTICALS SA. In United States, key buyers are AUROLOGISTICS LLC (AUROBINDO PHARMA, CIPLA USA INC UPS SUPPLY CHAIN SOLU, NORTHSTAR DISTRIBUTION CENTER 8912.
This geographic spread reflects Emtricitabine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Emtricitabine Go? Top Importing Countries & Their Buyers
Trade flow of Emtricitabine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1South Africa
South Africa ranks as the first-largest destination for Emtricitabine imports from India, with a total trade value of $31.3M across 30 shipments — representing a 26.2% share of all Emtricitabine exports. The average shipment value of $1.0M is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Emtricitabine importers in South Africa: VIATRIS HEALTHCARE (PTY) LTD, is the largest buyer, accounting for 46.2% ($14.5M) of this market's total imports.
• VIATRIS HEALTHCARE (PTY) LTD, — $14.5M (46.2% of South Africa's total)
• MACLEODS PHARMACEUTICALS SA — $12.0M (38.5% of South Africa's total)
Key Insight: South Africa's per-shipment average of $1.0M (1815% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Emtricitabine imports from India.
2United States
United States ranks as the second-largest destination for Emtricitabine imports from India, with a total trade value of $15.6M across 101 shipments — representing a 13.1% share of all Emtricitabine exports. The average shipment value of $154.8K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.
Named Emtricitabine importers in United States: AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest buyer, accounting for 14.0% ($2.2M) of this market's total imports.
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $2.2M (14.0% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $1.9M (12.0% of United States's total)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.7M (10.8% of United States's total)
Key Insight: United States's per-shipment average of $154.8K (185% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Emtricitabine imports from India.
3Zimbabwe
Zimbabwe ranks as the third-largest destination for Emtricitabine imports from India, with a total trade value of $10.4M across 2 shipments — representing a 8.7% share of all Emtricitabine exports. The average shipment value of $5.2M is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Emtricitabine importers in Zimbabwe: NATIONAL AIDS COUNCIL (NAC), is the largest buyer, accounting for 94.8% ($9.9M) of this market's total imports.
• NATIONAL AIDS COUNCIL (NAC), — $9.9M (94.8% of Zimbabwe's total)
Key Insight: Zimbabwe's per-shipment average of $5.2M (9484% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Zimbabwe is a key market for Emtricitabine imports from India.
4United Kingdom
United Kingdom ranks as the fourth-largest destination for Emtricitabine imports from India, with a total trade value of $9.8M across 21 shipments — representing a 8.2% share of all Emtricitabine exports. The average shipment value of $468.4K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Emtricitabine importers in United Kingdom: LUPIN HEALTHCARE (UK) LIMITED is the largest buyer, accounting for 43.9% ($4.3M) of this market's total imports.
• LUPIN HEALTHCARE (UK) LIMITED — $4.3M (43.9% of United Kingdom's total)
• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M (36.7% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $468.4K (761% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Emtricitabine imports from India.
5France
France ranks as the fifth-largest destination for Emtricitabine imports from India, with a total trade value of $8.9M across 12 shipments — representing a 7.4% share of all Emtricitabine exports. The average shipment value of $738.2K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Emtricitabine importers in France: ZYDUS FRANCE is the largest buyer, accounting for 92.6% ($8.2M) of this market's total imports.
• ZYDUS FRANCE — $8.2M (92.6% of France's total)
Key Insight: France's per-shipment average of $738.2K (1256% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Emtricitabine imports from India.
People Also Ask — Emtricitabine Supplier & Trade Network
Who are the top suppliers of Emtricitabine from India?+
Which companies buy Emtricitabine from Indian manufacturers?+
Where does Emtricitabine exported from India go?+
What is the market share of the top Emtricitabine supplier from India?+
What is the average shipment value for Emtricitabine exports from India?+
Is Emtricitabine manufactured in India and exported globally?+
Which country imports the most Emtricitabine from India?+
Who are the buyers of Emtricitabine in United States?+
How concentrated is the Emtricitabine supplier market in India?+
How do I find verified buyers for Emtricitabine in specific countries?+
Emtricitabine Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Emtricitabine exporter with a 22.8% market share and $27.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 141 suppliers collectively account for 56.5% of all tracked Emtricitabine exports, with a combined trade value of $119.4M.
- 3South Africa is the largest destination market, absorbing 26.2% of India's Emtricitabine exports ($31.3M). United States (13.1%) and Zimbabwe (8.7%) follow.
- 4With 2.2K total shipments averaging $54.4K each, the Emtricitabine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include VIATRIS HEALTHCARE (PTY) LTD,, NATIONAL AIDS COUNCIL (NAC),, MACLEODS PHARMACEUTICALS SA, ZYDUS FRANCE — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 117 countries
Network value: $119.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Emtricitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Emtricitabine.
- 2.Flow Mapping: 141 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,194 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 117 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,194 Verified Shipments
141 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists